RAD51C and breast cancer: In conclusion, in this study, we described that 14% of non-BRCA patients with BC/OC tumors are carriers of pathogenic variants in other genes, particularly CHEK2, RAD51C, ATM, MLH1, MSH2, RECQL, all related with the BRCA1/2 DNA repair pathway.